Challenges for the Development of Ribonucleoside Analogues As Inducers of Error Catastrophe
Overview
Infectious Diseases
Microbiology
Authors
Affiliations
RNA viruses are responsible for numerous human diseases; some of these viruses are also potential agents of bioterrorism. In general, the replication of RNA viruses results in the incorporation of at least one mutation per round of replication, leading to a heterogeneous population, termed a quasispecies. The antiviral nucleoside ribavirin has been shown to cause an increase in the mutation frequency of RNA viruses. This increase in mutation frequency leads to a loss of viability due to error catastrophe. In this article, we review lethal mutagenesis as an antiviral strategy, emphasizing the challenges remaining for the development of lethal mutagenesis into a practical clinical approach.
A Virus Is a Community: Diversity within Negative-Sense RNA Virus Populations.
Gonzalez Aparicio L, Lopez C, Felt S Microbiol Mol Biol Rev. 2022; 86(3):e0008621.
PMID: 35658541 PMC: 9491172. DOI: 10.1128/mmbr.00086-21.
Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1.
Dapp M, Bonnac L, Patterson S, Mansky L J Virol. 2013; 88(1):354-63.
PMID: 24155391 PMC: 3911745. DOI: 10.1128/JVI.02444-13.
Moustafa I, Shen H, Morton B, Colina C, Cameron C J Mol Biol. 2011; 410(1):159-81.
PMID: 21575642 PMC: 3114172. DOI: 10.1016/j.jmb.2011.04.078.
Wu R, Smidansky E, Oh H, Takhampunya R, Padmanabhan R, Cameron C J Med Chem. 2010; 53(22):7958-66.
PMID: 20964406 PMC: 2990348. DOI: 10.1021/jm100593s.
Therapeutically targeting RNA viruses via lethal mutagenesis.
Graci J, Cameron C Future Virol. 2009; 3(6):553-566.
PMID: 19727424 PMC: 2630198. DOI: 10.2217/17460794.3.6.553.